Healthcare provider profile · identity verified

Todd Michael Garrett, M.D.

Internal Medicine · CEDAR CITY, UT · NPI 1255537429

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	866	259
Levothyroxine Sodium	Levothyroxine Sodium	687	169
Amlodipine Besylate	Amlodipine Besylate	521	150
Losartan Potassium	Losartan Potassium	477	136
Omeprazole	Omeprazole	468	139
Lisinopril	Lisinopril	439	125
Pantoprazole Sodium	Pantoprazole Sodium	388	123
Potassium Chloride	Potassium Chloride	362	106
Trazodone Hcl	Trazodone Hcl	357	98
Rosuvastatin Calcium	Rosuvastatin Calcium	355	118
Gabapentin	Gabapentin	328	95
Metformin Hcl	Metformin Hcl	291	81
Metoprolol Succinate	Metoprolol Succinate	274	82
Furosemide	Furosemide	260	76
Pravastatin Sodium	Pravastatin Sodium	246	69
Eliquis	Apixaban	235	55
Tamsulosin Hcl	Tamsulosin Hcl	230	74
Sertraline Hcl	Sertraline Hcl	228	57
Duloxetine Hcl	Duloxetine Hcl	211	61
Montelukast Sodium	Montelukast Sodium	189	56
Metoprolol Tartrate	Metoprolol Tartrate	151	48
Pioglitazone Hcl	Pioglitazone Hcl	145	42
Simvastatin	Simvastatin	145	37
Diclofenac Sodium	Diclofenac Sodium	141	65
Escitalopram Oxalate	Escitalopram Oxalate	139	43
Glipizide	Glipizide	138	48
Alendronate Sodium	Alendronate Sodium	137	52
Finasteride	Finasteride	137	35
Hydrochlorothiazide	Hydrochlorothiazide	136	41
Zolpidem Tartrate	Zolpidem Tartrate	135	31
Fluticasone Propionate	Fluticasone Propionate	132	74
Albuterol Sulfate Hfa	Albuterol Sulfate	122	55
Ozempic	Semaglutide	122	25
Carvedilol	Carvedilol	120	35
Bupropion Xl	Bupropion Hcl	116	30
Allopurinol	Allopurinol	114	39
Estradiol	Estradiol	113	35
Citalopram Hbr	Citalopram Hydrobromide	101	27
Clopidogrel	Clopidogrel Bisulfate	99	29
Xarelto	Rivaroxaban	98	20
Famotidine	Famotidine	95	34
Cephalexin	Cephalexin	92	68
Spironolactone	Spironolactone	91	20
Buspirone Hcl	Buspirone Hcl	90	21
Pregabalin	Pregabalin	90	22
Atenolol	Atenolol	86	25
Ondansetron Hcl	Ondansetron Hcl	82	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	19
Tramadol Hcl	Tramadol Hcl	81	24
Ropinirole Hcl	Ropinirole Hcl	80	22
Fluoxetine Hcl	Fluoxetine Hcl	79	23
Jardiance	Empagliflozin	78	22
Prednisone	Prednisone	77	45
Ezetimibe	Ezetimibe	63	22
Synthroid	Levothyroxine Sodium	63	17
Venlafaxine Hcl Er	Venlafaxine Hcl	61	15
Amitriptyline Hcl	Amitriptyline Hcl	59	20
Meloxicam	Meloxicam	58	14
Metformin Hcl Er	Metformin Hcl	57	18
Trulicity	Dulaglutide	57	13
Alprazolam	Alprazolam	56	11
Sodium Chloride	0.9 % Sodium Chloride	56	suppressed
Magnesium Sulfate	Magnesium Sulfate	52	suppressed
Paroxetine Hcl	Paroxetine Hcl	49	11
Propranolol Hcl	Propranolol Hcl	49	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	48	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	13
Celecoxib	Celecoxib	46	14
Oxybutynin Chloride	Oxybutynin Chloride	45	15
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	44	12
Chlorthalidone	Chlorthalidone	43	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	16
Fenofibrate	Fenofibrate	43	13
Doxazosin Mesylate	Doxazosin Mesylate	42	11
Lorazepam	Lorazepam	42	11
Valacyclovir	Valacyclovir Hcl	42	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	41	13
Lovastatin	Lovastatin	41	13
Myrbetriq	Mirabegron	39	12
Sumatriptan Succinate	Sumatriptan Succinate	39	suppressed
Aripiprazole	Aripiprazole	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	12
Zolpidem Tartrate Er	Zolpidem Tartrate	36	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	26
Torsemide	Torsemide	35	11
Donepezil Hcl	Donepezil Hcl	34	14
Doxycycline Hyclate	Doxycycline Hyclate	34	30
Nifedipine Er	Nifedipine	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Colestipol Hcl	Colestipol Hcl	33	suppressed
Glimepiride	Glimepiride	33	suppressed
Liothyronine Sodium	Liothyronine Sodium	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Prazosin Hcl	Prazosin Hcl	30	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	12
Hydroxyzine Hcl	Hydroxyzine Hcl	29	16
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	23
Ibandronate Sodium	Ibandronate Sodium	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	22
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Humalog Kwikpen U-100	Insulin Lispro	25	suppressed
Warfarin Sodium	Warfarin Sodium	25	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Diltiazem Hcl	Diltiazem Hcl	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nystatin	Nystatin	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	19
Bisoprolol Fumarate	Bisoprolol Fumarate	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Farxiga	Dapagliflozin Propanediol	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Linzess	Linaclotide	18	suppressed
Ramipril	Ramipril	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Fluconazole	Fluconazole	17	13
Topiramate	Topiramate	17	suppressed
Amoxicillin	Amoxicillin	16	14
Clonazepam	Clonazepam	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	16	11
Lansoprazole	Lansoprazole	16	suppressed
Metronidazole	Metronidazole	16	12
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Vraylar	Cariprazine Hcl	13	suppressed
Armodafinil	Armodafinil	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Estradiol (Once Weekly)	Estradiol	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Repatha Syringe	Evolocumab	12	suppressed
Risperidone	Risperidone	12	suppressed
Baclofen	Baclofen	11	suppressed
Cefdinir	Cefdinir	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Primidone	Primidone	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error